Digital Brands (DBGI) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 14, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-40400
Entity Registrant Name	Digital Brands Group, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-1942864
Entity Address, Address Line One	1400 Lavaca Street
Entity Address, City or Town	Austin
Entity Address State Or Province	TX
Entity Address, Postal Zip Code	78701
City Area Code	209
Local Phone Number	651-0172
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		857,859
Entity Central Index Key	0001668010
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock
Document and Entity Information
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	DBGI
Security Exchange Name	NASDAQ
Warrants, each exercisable to purchase one share of common stock
Document and Entity Information
Title of 12(b) Security	Warrants, each exercisable to purchase one share of common stock
Trading Symbol	DBGIW
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,067,259	$ 1,275,616
Accounts receivable, net	419,125	583,368
Due from factor, net	258,825	839,400
Inventory	4,710,327	5,122,564
Prepaid expenses and other current assets	1,194,544	766,901
Assets per discontinued operations, current		241,544
Total current assets	7,650,080	8,829,393
Property, equipment and software, net	98,170	104,512
Goodwill	8,973,501	8,973,501
Intangible assets, net	10,701,764	12,906,238
Deposits	106,547	193,926
Right of use asset	207,745	102,349
Assets per discontinued operations		2,628,136
Total assets	27,737,807	33,738,055
Current liabilities:
Accounts payable	8,273,340	8,016,173
Accrued expenses and other liabilities	4,781,632	3,936,920
Due to related parties	336,250	555,217
Contingent consideration liability		12,098,475
Convertible note payable, net	100,000	2,721,800
Accrued interest payable	1,888,014	1,561,795
Loan payable, current	1,878,023	1,829,629
Promissory note payable, net	4,899,018	9,000,000
Right of use liability, current portion	203,401	102,349
Liabilities per discontinued operations, current		1,071,433
Total current liabilities	22,359,678	40,893,791
Loan payable	150,000	150,000
Right of use liability	6,784
Liabilities per discontinued operations		147,438
Total liabilities	22,516,462	41,191,229
Commitments and contingencies
Stockholders' equity (deficit):
Additional paid-in capital	115,496,683	96,294,123
Accumulated deficit	(110,275,397)	(103,747,316)
Total stockholders' equity (deficit)	5,221,345	(7,453,174)
Total liabilities and stockholders' equity (deficit)	27,737,807	33,738,055
Undesignated preferred stock
Stockholders' equity (deficit):
Preferred stock
Series A Convertible Preferred Stock
Stockholders' equity (deficit):
Preferred stock	1	1
Series C convertible preferred stock
Stockholders' equity (deficit):
Preferred stock	1
Common stock
Stockholders' equity (deficit):
Common stock, $0.0001 par, 1,000,000,000 shares authorized, 578,090 and 317,502 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	$ 58	$ 18

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Common stock par value	$ 0.0001	$ 0.0001
Common stock, share authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, share issued (in shares)	578,090	317,502
Common stock, shares outstanding (in shares)	578,090	317,502
Undesignated preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Series A Convertible Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	6,800	6,800
Preferred stock, shares issued (in shares)	6,300	6,300
Preferred stock, shares outstanding (in shares)	6,300	6,300
Series C convertible preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	5,671	5,671
Preferred stock, shares issued (in shares)	5,671	0
Preferred stock, shares outstanding (in shares)	5,671	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Net revenues	$ 3,257,332	$ 2,658,844	$ 12,127,135	$ 7,937,406
Cost of net revenues	1,554,044	1,700,547	6,094,532	5,252,943
Gross profit	1,703,288	958,298	6,032,603	2,684,464
Operating expenses:
General and administrative	3,735,527	2,979,915	12,115,590	11,053,536
Sales and marketing	1,151,377	1,022,331	3,188,054	3,252,418
Distribution	238,546	97,737	750,945	522,510
Change in fair value of contingent consideration		(702,885)	(10,698,475)	6,418,355
Total operating expenses	5,125,450	3,397,098	5,356,114	21,246,820
Income (loss) from operations	(3,422,162)	(2,438,800)	676,489	(18,562,356)
Other income (expense):
Interest expense	(1,956,080)	(2,271,548)	(4,907,567)	(6,002,160)
Other non-operating income (expenses)	(57,752)	(23,690)	(734,501)	2,629,685
Total other income (expense), net	(2,013,832)	(2,295,238)	(5,642,068)	(3,372,475)
Net loss from continuing operations	(5,435,994)	(4,734,038)	(4,965,579)	(21,934,831)
Income (loss) from discontinued operations, net of tax		(160,433)	(1,562,503)	(326,507)
Net loss	$ (5,435,994)	$ (4,894,471)	$ (6,528,082)	$ (22,261,338)
Weighted average common shares outstanding - basic	373,498	21,150	283,673	13,649
Weighted average common shares outstanding -diluted	373,498	21,150	283,673	13,649
Net loss from continuing per common share - basic	$ (14.55)	$ (223.83)	$ (17.50)	$ (1,607.05)
Net loss from continuing per common share - diluted	$ (14.55)	$ (223.83)	$ (17.50)	$ (1,607.05)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Preferred Stock Series B Preferred Stock	Preferred Stock Series A Convertible Preferred Stock	Preferred Stock Series C convertible preferred stock	Common Stock	Accumulated Deficit	Additional Paid-in Capital	Total
Beginning balance at Dec. 31, 2021				$ 1	$ (65,703,954)	$ 58,614,172	$ (7,089,781)
Beginning balance (in shares) at Dec. 31, 2021				5,201
Conversion of notes into common stock						1,201,582	1,201,582
Conversion of notes into common stock (in shares)				350
Stock-based compensation						139,093	139,093
Net Income (loss)					(7,832,942)		(7,832,942)
Ending balance (in shares) at Mar. 31, 2022				5,550
Ending balance at Mar. 31, 2022				$ 1	(73,536,896)	59,954,847	(13,582,048)
Beginning balance at Dec. 31, 2021				$ 1	(65,703,954)	58,614,172	(7,089,781)
Beginning balance (in shares) at Dec. 31, 2021				5,201
Net Income (loss)							(22,261,338)
Ending balance (in shares) at Sep. 30, 2022		6,300		21,180
Ending balance at Sep. 30, 2022		$ 1		$ 2	(87,965,292)	75,440,991	(12,524,298)
Beginning balance at Mar. 31, 2022				$ 1	(73,536,896)	59,954,847	(13,582,048)
Beginning balance (in shares) at Mar. 31, 2022				5,550
Issuance of common stock in public offering				$ 1		9,347,449	9,347,450
Issuance of common stock in public offering (in shares)				14,956
Offering costs						(1,930,486)	(1,930,486)
Conversion of notes and derivative liability into common stock						600,790	600,790
Conversion of notes and derivative liability into common stock (in shares)				644
Stock-based compensation						119,759	119,759
Net Income (loss)					(9,533,924)		(9,533,924)
Warrants issued in connection with note						98,241	98,241
Ending balance (in shares) at Jun. 30, 2022				21,150
Ending balance at Jun. 30, 2022				$ 2	(83,070,820)	68,190,600	(14,880,218)
Stock-based compensation						110,093	110,093
Net Income (loss)					(4,894,471)		(4,894,471)
Common stock issued pursuant to consulting agreement						123,000	123,000
Common stock issued pursuant to consulting agreement (in shares)				30
Warrants issued in connection with note						692,299	692,299
Issuance of Series A preferred stock						25,000	25,000
Conversion of venture debt into Series A convertible preferred stock		$ 1				6,299,999	6,300,000
Conversion of venture debt into Series A convertible preferred stock (in shares)		6,300
Ending balance (in shares) at Sep. 30, 2022		6,300		21,180
Ending balance at Sep. 30, 2022		$ 1		$ 2	(87,965,292)	75,440,991	(12,524,298)
Beginning balance at Dec. 31, 2022		$ 1		$ 18	(103,747,316)	96,294,123	(7,453,174)
Beginning balance (in shares) at Dec. 31, 2022		6,300		178,758
Issuance of common stock pursuant to private placement, net of offering costs				$ 5		4,463,071	4,463,076
Issuance of common stock pursuant to private placement, net of offering costs (in shares)				51,086
Common stock issued for services						499,337	499,338
Common stock issued for services (in shares)				4,756
Shares and warrants issued with notes						658,494	658,494
Shares and warrants issued with notes (in shares)				4,400
Stock-based compensation						105,594	105,594
Net Income (loss)					(6,136,349)		(6,136,349)
Ending balance (in shares) at Mar. 31, 2023		6,300		238,999
Ending balance at Mar. 31, 2023		$ 1		$ 24	(109,883,665)	102,020,619	(7,863,021)
Beginning balance at Dec. 31, 2022		$ 1		$ 18	(103,747,316)	96,294,123	$ (7,453,174)
Beginning balance (in shares) at Dec. 31, 2022		6,300		178,758
Issuance of common stock pursuant to private placement, net of offering costs (in shares)							1,277,140
Net Income (loss)							$ (6,528,082)
Ending balance (in shares) at Sep. 30, 2023		6,300	5,761	578,090
Ending balance at Sep. 30, 2023		$ 1	$ 1	$ 58	(110,275,397)	115,496,683	5,221,345
Beginning balance at Mar. 31, 2023		$ 1		$ 24	(109,883,665)	102,020,619	(7,863,021)
Beginning balance (in shares) at Mar. 31, 2023		6,300		238,999
Conversion of notes into preferred stock			$ 1			5,759,177	5,759,177
Conversion of notes into preferred stock (in shares)			5,761
Issuance of Series B preferred stock						25,000	25,000
Issuance of Series B preferred stock (in shares)	1
Issuance of common stock pursuant to disposition				$ 8		1,357,035	1,357,043
Issuance of common stock pursuant to disposition (in shares)				78,103
Stock-based compensation						101,500	101,500
Net Income (loss)					5,044,261		5,044,262
Ending balance (in shares) at Jun. 30, 2023	1	6,300	5,761	317,102
Ending balance at Jun. 30, 2023		$ 1	$ 1	$ 32	(104,839,403)	109,263,331	4,423,961
Issuance of common stock pursuant to private placement, net of offering costs				$ 3		3,832,302	3,832,305
Issuance of common stock pursuant to private placement, net of offering costs (in shares)				32,000
Common stock issued for services				$ 11		1,157,079	1,157,090
Common stock issued for services (in shares)				105,174
Cancellation of Series B preferred stock						(25,000)	(25,000)
Cancellation of Series B preferred stock (in shares)	(1)
Stock-based compensation						101,417	101,417
Net Income (loss)					(5,435,994)		(5,435,994)
Exercise of warrants				$ 12		1,167,554	1,167,566
Exercise of warrants (in shares)				123,814
Ending balance (in shares) at Sep. 30, 2023		6,300	5,761	578,090
Ending balance at Sep. 30, 2023		$ 1	$ 1	$ 58	$ (110,275,397)	$ 115,496,683	$ 5,221,345

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (6,528,082)	$ (22,261,338)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,485,166	1,669,782
Amortization of loan discount and fees	1,956,355	4,610,234
Loss on extinguishment of debt	689,100
Loss on disposition of business	1,523,940
Stock-based compensation	308,511	491,945
Shares issued for services	1,656,417
Change in credit reserve	354,282	(26,429)
Change in fair value of contingent consideration	(10,698,475)	6,418,355
Discontinued operations	7,666
Fees incurred in connection with debt financings		48,245
Change in fair value of warrant liability		(18,223)
Change in fair value of derivative liability		(794,477)
Forgiveness of Payroll Protection Program		(1,760,755)
Changes in operating assets and liabilities:
Accounts receivable, net	153,479	(289,061)
Due from factor, net	72,220	433,671
Inventory	514,955	100,006
Prepaid expenses and other current assets	(366,615)	(522,434)
Accounts payable	182,242	382,943
Accrued expenses and other liabilities	1,088,763	1,715,221
Deferred revenue	(183,782)	119,977
Accrued interest	326,219	992,482
Net cash used in operating activities	(6,457,638)	(8,689,857)
Cash flows from investing activities:
Cash disposed	(18,192)
Purchase of property, equipment and software	(27,855)	(5,533)
Deposits	87,378
Net cash provided by (used in) investing activities	41,331	(5,533)
Cash flows from financing activities:
Proceeds (repayments) from related party advances	(218,967)	(162,692)
Advances (repayments) from factor	154,073	(60,735)
Proceeds from venture debt		237,500
Issuance of loans and note payable	5,799,989	248,858
Repayments of convertible and promissory notes	(8,840,092)	(3,068,750)
Issuance of convertible notes payable		3,751,250
Exercise of warrants	1,167,566
Issuance of common stock in public offering	10,000,003	9,347,450
Offering costs	(1,854,622)	(1,930,486)
Net cash provided by financing activities	6,207,950	8,362,395
Net change in cash and cash equivalents	(208,357)	(332,995)
Cash and cash equivalents at beginning of period	1,275,616	528,394
Cash and cash equivalents at end of period	1,067,259	195,399
Supplemental disclosure of cash flow information:
Cash paid for interest	1,176,305	318,576
Supplemental disclosure of non-cash investing and financing activities:
Conversion of notes into common stock		1,802,372
Conversion of notes into preferred stock	5,759,177
Right of use asset	$ 467,738	152,387
Warrants issued in connection with note		790,540
Derivative liability in connection with convertible note		559,957
Conversion of related party notes and payables into preferred and common stock		25,000
Conversion of venture debt into preferred stock		$ 6,300,000

NATURE OF OPERATIONS

NATURE OF OPERATIONS	9 Months Ended
	Sep. 30, 2023
NATURE OF OPERATIONS
NATURE OF OPERATIONS	NOTE 1: NATURE OF OPERATIONS Digital Brands Group, Inc. (the “Company” or “DBG”), was organized on September 17, 2012 under the laws of Delaware as a limited liability company under the name Denim.LA LLC. The Company converted to a Delaware corporation on January 30, 2013 and changed its name to Denim.LA, Inc. Effective December 31, 2020, the Company changed its name to Digital Brands Group, Inc. (DBG). The Company is a curated collection of lifestyle brands, including Bailey 44, DSTLD, Harper & Jones, Stateside and ACE Studios, that offers a variety of apparel products through direct-to-consumer and wholesale distribution. On February 12, 2020, Denim.LA, Inc. entered into an Agreement and Plan of Merger with Bailey 44, LLC (“Bailey”), a Delaware limited liability company. On the acquisition date, Bailey 44, LLC became a wholly owned subsidiary of the Company. On May 18, 2021, the Company closed its acquisition of Harper & Jones, LLC (“H&J”) pursuant to its Membership Interest Stock Purchase Agreement with D. Jones Tailored Collection, Ltd. to purchase 100% of the issued and outstanding equity of Harper & Jones, LLC. On the acquisition date, H&J became a wholly owned subsidiary of the Company. On August 30, 2021, the Company closed its acquisition of Mosbest, LLC dba Stateside (“Stateside”) pursuant to its Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Stateside. On the acquisition date, Stateside became a wholly owned subsidiary of the Company. On December 30, 2022, the Company closed its previously announced acquisition of Sunnyside, LLC dba Sundry (“Sundry”) pursuant to its Second Amended and Restated Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Sundry. On the acquisition date, Sundry became a wholly owned subsidiary of the Company. On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 1,952,580 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. The H&J Settlement was accounted for a business disposition.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2023
GOING CONCERN
GOING CONCERN	NOTE 2: GOING CONCERN The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated profits since inception, has sustained net losses of $6,528,082 and $22,261,338 for the nine months ended September 30, 2023 and 2022, respectively, and has incurred negative cash flows from operations for the nine months ended September 30, 2023 and 2022. The Company has historically lacked liquidity to satisfy obligations as they come due and as of September 30, 2023, and the Company had a working capital deficit of $14,709,598. These factors, among others, arise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to continue to generate operating losses for the foreseeable future. The accompanying consolidated financial statements do not include any adjustments as a result of this uncertainty. The Company’s ability to continue as a going concern for the next 12 months from the date the financial statements were available to be issued is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. Through the date the financial statements were available to be issued, the Company has been primarily financed through the issuance of capital stock and debt. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations. No assurance can be given that the Company will be successful in these efforts.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Sep. 30, 2023
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS	NOTE 4: DISCONTINUED OPERATIONS On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 1,952,580 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J. The components of the disposition are as follows: ​ ​ ​ ​ Cash payment due to H&J Seller $ (229,000) Common shares issued to H&J Seller* ​ (1,357,043) Total fair value of consideration received (given) ​ $ (1,586,043) ​ ​ ​ ​ Carrying amount of assets and liabilities ​ Cash and cash equivalents ​ 18,192 Accounts receivable, net ​ 55,782 Prepaid expenses and other current assets ​ 25,115 Goodwill ​ 1,130,311 Intangible assets, net ​ 1,246,915 Deposits ​ 4,416 Accounts payable ​ (40,028) Accrued expenses and other liabilities ​ (734,068) Deferred revenue ​ (18,347) Due to related parties ​ (1,008) Contingent consideration ​ ​ (1,400,000) Loan payable ​ (219,894) Note payable - related party ​ (129,489) Total carrying amount of assets and liabilities ​ (62,103) ​ ​ ​ ​ Loss on disposition of business ​ $ (1,523,940) *Represents the fair value of 1,952,580 shares of common stock issued to D. Jones. Through September 30, 2023, the Company has made payments to D. Jones totaling $200,000. The remaining balance of $29,000 is included in accrued expenses and other liabilities on the consolidated balance sheet. The loss of disposition of business of $1,523,940 was included in income (loss) from discontinued operations, net of tax in the consolidated statements of operations. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022. The results of the discontinued operations of HJ for the three and nine months ended September 30, 2023 and 2022 consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Nine Months Ended ​ ​ September 30, ​ September 30, ​ ​ 2023 2022 ​ 2023 2022 Net revenues ​ $ — ​ $ 765,678 ​ $ 1,405,482 ​ $ 2,658,527 Cost of net revenues ​ — ​ 356,349 ​ 565,621 ​ 961,761 Gross profit ​ — ​ 409,329 ​ 839,861 ​ 1,696,765 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Operating expenses: ​ ​ ​ ​ ​ ​ ​ ​ General and administrative ​ — ​ 359,205 ​ 520,582 ​ 1,256,078 Sales and marketing ​ — ​ 203,087 ​ 346,167 ​ 718,862 Distribution ​ — ​ — ​ — ​ — Change in fair value of contingent consideration ​ — ​ — ​ — ​ — Total operating expenses ​ — ​ 562,293 ​ 866,749 ​ 1,974,940 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Loss from operations ​ — ​ (152,962) ​ (26,888) ​ (278,175) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ Interest expense ​ — ​ (7,470) ​ (11,675) ​ (48,332) Loss on disposition of business ​ — ​ — ​ (1,523,940) ​ — Other non-operating income (expenses) ​ — ​ — ​ — ​ — Total other income (expense), net ​ — ​ (7,470) ​ (1,535,615) ​ (48,332) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Income tax benefit (provision) ​ — ​ — ​ — ​ — Net loss from discontinued operations ​ $ — ​ $ (160,432) ​ $ (1,562,503) ​ $ (326,507) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average common shares outstanding – basic and diluted ​ 373,498 ​ 21,150 ​ 283,673 ​ 9,836 Net loss from discontinued operations per common share – basic and diluted ​ $ — ​ $ (7.59) ​ $ (5.51) ​ $ (33.19) ​

DUE FROM FACTOR

DUE FROM FACTOR	9 Months Ended
	Sep. 30, 2023
DUE FROM FACTOR
DUE FROM FACTOR	NOTE 5: DUE FROM FACTOR Due to/from factor consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Outstanding receivables: ​ ​ ​ ​ ​ ​ Without recourse ​ $ 308,918 ​ $ 1,680,042 With recourse ​ 29,843 ​ 65,411 Matured funds and deposits ​ ​ 103,095 ​ ​ 81,055 Advances ​ ​ (172,285) ​ ​ (632,826) Credits due customers ​ ​ (10,746) ​ ​ (354,282) ​ ​ $ 258,825 ​ $ 839,400 ​

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2023
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS	NOTE 6: GOODWILL AND INTANGIBLE ASSETS The following is a summary of goodwill attributable to each business combination: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31 ​ ​ 2023 ​ 2022 Bailey ​ $ 3,158,123 ​ $ 3,158,123 Stateside ​ 2,104,056 ​ 2,104,056 Sundry ​ 3,711,322 ​ 3,711,322 ​ ​ $ 8,973,501 ​ $ 8,973,501 ​ In connection with the H&J disposition, the Company derecognized $1,130,311 in goodwill. The following table summarizes information relating to the Company’s identifiable intangible assets as of September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Accumulated Carrying ​ ​ Amount ​ Amortization ​ Value Amortized: ​ ​ ​ Customer relationships ​ $ 9,734,560 ​ $ (4,874,676) ​ $ 4,859,884 ​ ​ $ 9,734,560 ​ $ (4,874,676) ​ $ 4,859,884 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Indefinite-lived: ​ ​ ​ ​ ​ ​ Brand name ​ $ 5,841,880 ​ ​ — ​ 5,841,880 ​ ​ $ 15,576,440 ​ $ (4,874,676) ​ $ 10,701,764 ​ In connection with the H&J disposition, the Company derecognized $1,246,915 in intangible assets. The Company recorded amortization expense of $719,547 and $537,813 during the three months ended September 30, 2023 and 2022, and $2,478,824 and $1,613,438 during the nine months ended September 30, 2023 and 2022, respectively, which is included in general and administrative expenses in the consolidated statements of operations.

LIABILITIES AND DEBT

LIABILITIES AND DEBT	9 Months Ended
	Sep. 30, 2023
LIABILITIES AND DEBT
LIABILITIES AND DEBT	NOTE 7: LIABILITIES AND DEBT Accrued Expenses and Other Liabilities The Company accrued expenses and other liabilities line in the consolidated balance sheets is comprised of the following as of September 30, 2023 and December 31,2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Accrued expenses ​ $ 489,628 ​ $ 668,714 Reserve for returns ​ — ​ 307,725 Payroll related liabilities ​ 3,792,438 ​ 2,618,870 Sales tax liability ​ 304,748 ​ 262,765 Other liabilities ​ 194,817 ​ 78,845 ​ ​ $ 4,781,632 ​ $ 3,936,920 ​ As of September 30, 2023, payroll liabilities included an aggregate of $1,406,403 in payroll taxes due to remit to federal and state authorities. Of this amount, $698,842 pertained to DBG and $707,561 pertained to Bailey44. The amounts are subject to further penalties and interest. The amounts are subject to further penalties and interest. As of September 30, 2023 and December 31, 2022, accrued expenses included $535,000 in accrued common stock issuances pursuant to an advisory agreement for services performed in 2022. The 200 shares of common stock owed per the agreement are expected to be issued in the fourth quarter of 2023. Convertible Debt 2020 Regulation D Offering As of September 30, 2023 and December 31, 2022, there was $100,000 remaining in outstanding principal that was not converted into equity. Convertible Promissory Note On December 29, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“December Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $4,000,000, consisting of original issue discount of $800,000. The Company received net proceeds of $3,000,000. The December Notes were due and payable on February 15, 2023. If the December Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the December Notes will be automatically increased to 120%; (2) the Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the December Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. In connection with the December Notes, the Company issued to the investors an aggregate of 469,480 warrants to purchase common stock at an exercise price equal to $4.26, and 60,000 shares of common stock. The Company recognized $428,200 as a debt discount for the fair value of the warrants and common shares using the Black-Scholes option model, resulting in a total debt discount of $1,378,200. In February 2023, the principal of $4,000,000 of the December Notes were fully repaid. The Company amortized $689,100 of debt discount up until the repayment date, and then recognized a loss on extinguishment of debt of $689,100 which is included in other non-operating income (expenses) on the consolidated statements of operations. The following is a summary of the convertible notes for the nine months ended September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Unamortized Convertible Note ​ ​ Principal ​ Debt Discount ​ Payable, Net Balance, December 31, 2022 ​ $ 4,100,000 ​ $ (1,378,200) ​ $ 2,721,800 Repayments of notes ​ (4,000,000) ​ — ​ (4,000,000) Amortization of debt discount ​ — ​ 689,100 ​ 689,100 Loss on extinguishment of debt ​ — ​ 689,100 ​ 689,100 Balance, September 30, 2023 ​ $ 100,000 ​ $ — ​ $ 100,000 ​ During the nine months ended September 30, 2022, the Company converted an aggregate of $888,930 in outstanding principal into 350 shares of common stock. During the nine months ended September 30, 2023 and 2022, the Company amortized $689,100 and $1,792,060, respectively of debt discount to interest expense pertaining to convertible notes. In January 2023, the Company issued 110,000 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. Loan Payable — PPP and SBA Loan As of both September 30, 2023 and December 31, 2022, Bailey had an outstanding PPP Loan balance of $933,295 and matures in 2026. Merchant Advances In 2022, the Company obtained several merchant advances. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. As of December 31, 2022, $896,334 remained outstanding. During the nine months ended September 30, 2023, the Company received additional proceeds totaling $2,880,238 and made repayments totaling $3,338,572. As of September 30, 2023, the remaining principal outstanding was $438,000. In connection with these advances, the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25 to the lender in connection with its merchant advances. In 2023, the Company obtained merchant advances totaling $902,051 from Shopify Capital and another lender, and made repayments totaling $395,323. As of September 30, 2023, the remaining principal outstanding was $506,728. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a daily basis. ​ Promissory Note Payable ​ As of September 30, 2023 and December 31, 2022, the outstanding principal on the note to the sellers of Bailey was $3,500,000. The maturity date was December 31, 2022. On July 5, 2023, the parties agreed to extend the maturity date to June 30, 2024. Interest expense was $105,000 and $105,000 for the three months ended September 30, 2023 and 2022 and $315,000 and $315,000 for the nine months ended September 30, 2023 and 2022, all respectively, which was accrued and unpaid as of September 30, 2023. The Company issued a promissory note in the principal amount of $5,500,000 to the Sundry Holders pursuant to the Sundry acquisition. The note bears interest at 8% per annum and matures on February 15, 2023. In February 2023, the parties verbally agreed to extend the maturity date to December 31, 2023. Interest expense was $149,177 and $259,177 for the three and six months ended June 30, 2023, respectively. On June 21, 2023, the Company and the Sundry Holders executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued 5,761 shares of Series C Convertible Preferred Stock to the Sundry Holders for $1,000 per share (see Note 7). The shares were issued pursuant to the cancellation of the Sundry Holders’ entire principal amount of $5,500,000 and accrued interest of $259,177. In March 2023, the Company and various purchasers executed a Securities Purchase Agreement (“March 2023 Notes”) whereby the investors purchased from the Company promissory notes in the aggregate principal amount of $2,458,750, consisting of original issue discount of $608,750. The Company received net proceeds of $1,850,000 after additional fees. The March 2023 Notes are due and payable on September 30, 2023 (the “Maturity Date”). The Company will also have the option to prepay the Notes with no penalties at any time prior to the Maturity Date. If the Company completes a debt or equity financing of less than $7,500,000, the Company is required to repay 50% of the remaining balance of the March 2023 Notes. Following such 50% repayment, the Company must also use any proceeds from any subsequent debt or equity financing to repay the March 2023 Notes. Upon the closing of any debt or equity financing of $7,500,000 or greater, the Company is required to repay 100% of the Notes with no penalties. There is no additional interest after the 20% original interest discount. Upon the Company’s equity financing in September 2023, the Company repaid an aggregate $1,059,732 in principal to the respective noteholders. The Company recognized a debt discount of $608,750, which was fully amortized through September 30, 2023. This note is currently in default, however the parties are currently working on an extension to the Maturity Date. ​ The following is a summary of promissory notes payable, net: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Bailey Note ​ $ 3,500,000 ​ $ 3,500,000 Sundry Note ​ — ​ 5,500,000 March 2023 Notes - principal ​ 1,399,018 ​ — Promissory note payable, net ​ $ 4,899,018 ​ $ 9,000,000 ​

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2023
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8: STOCKHOLDERS’ DEFICIT On January 11, 2023, the Company, entered into a Securities Purchase Agreement with a certain accredited investor, pursuant to which the Company agreed to issue and sell, in a private placement (the “January Private Placement”), an aggregate of 475,000 shares of the Company’s common stock (“Common Stock”), and accompanying warrants to purchase 475,000 shares of Common Stock, at a combined purchase price of $3.915 per share and Common Warrant, and (ii) 802,140 pre-funded warrants exercisable for 802,140 shares of Common Stock, and accompanying common warrants to purchase 802,140 shares of Common Stock, at a combined purchase price of $3.915 per pre-funded warrant and accompanying common warrant, to the investors, for aggregate gross proceeds from the January Private Placement of approximately $5 million before deducting placement agent fees and related offering expenses. As a result of the transaction, the Company issued 1,277,140 shares of Common Stock, including the 475,000 shares and the immediate exercise of 802,140 pre-funded warrants, for gross proceeds of $5.0 million. The Company received net proceeds of $4.3 million after deducting placement agent fees and offering expenses. In January 2023, the Company issued 110,000 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. In March 2023, the Company issued an aggregate of 118,890 shares of common stock to Sundry executives based on their employment agreements with the Company. The fair value of $499,338, or $4.20 per share as determined by the agreements, was included in general and administrative expenses in the consolidated statements of operations. In June 2023, the Company issued 1,952,580 shares of common stock to D. Jones at a fair value of $1,357,043 pursuant to the H&J Settlement Agreement. On August 31, 2023, the Company entered into a Securities Purchase Agreement with a certain accredited investor, pursuant to which the Company agreed to issue and sell, in a private placement (the “August Private Placement”), an aggregate of 32,000 shares of the Company’s Common Stock and accompanying Series A warrants to purchase up to 32,000 shares of Common Stock and Series B warrants to purchase up to 32,000 shares of Common Stock at a combined purchase price of $9.73 per share and common warrants, and (ii) 481,875 pre-funded warrants exercisable for 481,875 shares of Common Stock, and accompanying Series A Warrants to purchase up to 481,875 shares of Common Stock and Series B Warrants to purchase up to 481,875 shares of Common Stock, at a combined purchase price of $9.73, for aggregate gross proceeds from the August Private Placement of approximately $5 million. The Company received net proceeds of $3.8 million after deducting placement agent fees and offering expenses. Through September 30, 2023, none of the pre-funded warrants from the August Private Placement had been exercised for shares of Common Stock. In connection with the August Private Placement, the Company entered into a warrant amendment (the “Warrant Amendment”) with certain investors to amend certain existing warrants to purchase up to 196,542 shares of Common Stock that were previously issued in December 2022 and January 2023 to the investors, with an exercise price of $131.25 per share and $95.00 per share, respectively (the “Amended Warrants”) as follows: (i) to reduce the exercise price of the Amended Warrants to $9.43 per share, and (ii) to extend the original expiration date of the Amended Warrants so that they will terminate five one half In September 2023, the Company issued 42,782 shares in accrued amounts owed to Sundry executives based on their employment agreements for a total value of $500,000. On September 10, 2023, the non-employee members of the board of directors adopted a 2023 Stock Purchase Plan (the “2023 Plan”) to enable the Company to attract, retain and motivate its employees. Under the 2023 Plan, qualified employees can purchase shares of the Company’s common stock at fair market value by either the delivery of cash or the delivery of a form of acceptable non-recourse promissory note. The aggregate number of common stock issuable under the 2023 Plan shall not exceed 65,000 subject to certain adjustment provided under the 2023 Plan. Pursuant to the 2023 Plan, the Company issued an aggregate of 63,000 shares of common stock to certain employees and consultants with accompanying 5-year non-recourse promissory notes. The issuance of the shares were considered for services, and as such the Company recorded $657,090, or a fair value of $10.43 per share, in stock-based compensation which was included in general and administrative expenses int he consolidated statement of operations. Series A Preferred Stock On August 31, 2022, the Company entered into a Subscription and Investment Representation Agreement with Hil Davis, its Chief Executive Officer, pursuant to which the Company agreed to issue 1 share of the Company's Series A Preferred Stock to for $25,000. The issuance of the preferred stock reduced the due to related party balance. The share of Series A Preferred Stock had 250,000,000 votes per share and voted together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposals to amend the Certificate of Incorporation to effect a reverse stock split of the Company’s common stock and to increase the authorized number of shares of the Company’s common stock. The terms of the Series A Preferred Stock provided that the outstanding share of Series A Preferred Stock would be redeemed in whole, but not in part, at any time: (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the approval of Proposals 2 and 6 presented at the Company’s 2022 annual shareholders meeting. On October 13, 2022, the outstanding share of the Company’s Series A Preferred Stock was redeemed. On September 13, 2023, the Company filed a certificate of cancellation (the “Series A Certificate of Cancellation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, cancelling the Series A Certificate of Designation relateing to the Series A Preferred Stock. Series B Preferred Stock On May 30, 2023, the Company entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with John Hilburn Davis IV, its Chief Executive Officer pursuant to which the Company agreed to issue and sell 1 share of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”) for $25,000. On May 30, 2023, the Company filed a certificate of designation (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the share of Series B Preferred Stock. The Certificate of Designation provides that the Series B Preferred Stock will have 250,000,000 votes per share of Series B Preferred Stock and will vote together with the outstanding shares of the Company’s common stock, par value 0.0001 per share (the “Common Stock”) and Series A Convertible Preferred Stock, par value 0.0001 per share (the “Series A Convertible Preferred Stock”) as a single class exclusively with respect to any proposal to amend the Company’s Sixth Amended and Restated Certificate of Incorporation (as may be amended and/or restated from time to time, the “Restated Certificate”) to effect a reverse stock split of the Company’s common stock. The Series B Preferred Stock will be voted, without action by the holder, on any such proposal in the same proportion as shares of Common Stock and Series A Convertible Preferred Stock are voted. The Series B Preferred Stock otherwise has no voting rights. The Series B Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series B Preferred Stock has no rights with respect to any distribution of assets of the Company, including upon a liquidation, bankruptcy, reorganization, merger, acquisition, sale, dissolution or winding up of the Company, whether voluntarily or involuntarily. The holder of the Series B Preferred Stock will not be entitled to receive dividends of any kind. The outstanding share of Series B Preferred Stock shall be redeemed in whole, but not in part, at any time (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Restated Certificate implementing a reverse stock split. Upon such redemption, the holder of the Series B Preferred Stock will receive consideration of $25,000 in cash. On September 13, 2023, the Company filed a certificate of cancellation (the “Series B Certificate of Cancellation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, cancelling the Series B Certificate of Designation, and thereby eliminating all Series B Preferred Stock. Series C Convertible Preferred Stock On June 21, 2023, the Company, on the one hand, and Moise Emquies, George Levy, Matthieu Leblan, Carol Ann Emquies, Jenny Murphy and Elodie Crichi (collectively, the “Sundry Investors”), on the other hand, executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued 5,761 shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) to the Sundry Investors at a purchase price of $1,000 per share. The Series C Preferred Stock is convertible into a number of shares of the Company’s Common Stock equal to $1,000 divided by an initial conversion price of $0.717 which represents the lower of (i) the closing price per share of the Common Stock as reported on the Nasdaq on June 20, 2023, and (ii) the average closing price per share of Common Stock as reported on the Nasdaq for the five On June 21, 2023, the Company filed the Certificate of Designation with the Secretary of State for the State of Delaware designating up to 5,761 shares out of the authorized but unissued shares of its preferred stock as Series C Convertible Preferred Stock. The following is a summary of the principal terms of the Series C Preferred Stock. Except for stock dividends or distributions for which adjustments are to be made pursuant to the Certificate of Designation, the holders of the Series C Preferred Stock (the “Series C Holders”) shall be entitled to receive, and the Company shall pay, dividends on shares of the Series C Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of the Series C Preferred Stock. The Series C Holders are entitled to vote as a class as expressly provided in the Certificate of Designation. The Series C Holders are also entitled to vote with the holders of shares of Common Stock, voting together as one class, on all matters in which the Series C Holders are permitted to vote with the class of shares of Common Stock. With respect to any vote with the class of Common Stock, each share of the Series C Preferred Stock shall entitle the Holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then convertible (subject to the ownership limitations specified in the Certificate of Designation) using the record date for determining the stockholders of the Company eligible to vote on such matters as the date as of which the conversion price is calculated. The Series C Preferred Stock shall rank (i) senior to all of the Common Stock; (ii) senior to Junior Securities; (iii) on parity with Parity Securities; and (iv) junior to Senior Securities, in each case, as to dividends or distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily. Subject to any superior liquidation rights of the holders of any Senior Securities of the Company and the rights of the Company’s existing and future creditors, upon a Liquidation, each Holder shall be entitled to be paid out of the assets of the Company legally available for distribution to stockholders, prior and in preference to any distribution of any of the assets or surplus funds of the Company to the holders of the Common Stock and Junior Securities and pari passu with any distribution to the holders of Parity Securities, an amount equal to the Stated Value (as defined in the Certificate of Designation) for each share of the Series C Preferred Stock held by such Holder and an amount equal to any accrued and unpaid dividends thereon, and thereafter the Series C Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of Common Stock would receive if the Series C Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paid pari passu with all holders of Common Stock. Each share of the Series C Preferred Stock shall be convertible, at any time and from time to time from and after June 21, 2023 at the option of the Holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of the Series C Preferred Stock ($1,000 as of June 21, 2023) by the Conversion Price. The conversion price for each share of the Series C Preferred Stock is $0.717, which is the lower of (a) the closing price per share of the Common Stock as reported on the Nasdaq Capital Market on June 20, 2023 (the trading day before the date of the Sundry SPA), and (b) the average closing price per share of Common Stock as reported on the Nasdaq Capital Market for the five The Company has the option to redeem any or all of the then outstanding Series C Preferred Stock at 112% of the then Stated Value any time after June 21, 2023 and so long as there is an effective Registration Statement covering the shares issuable upon conversion of the Series C Preferred Stock.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 9: RELATED PARTY TRANSACTIONS During the nine months ended September 30, 2023 and 2022, the Company made net repayments for amounts due to related parties totaling $218,967 and $162,692, respectively. As of September 30, 2023 and December 31, 2022, amounts due to related parties were $336,250 and $556,225, respectively. The advances are unsecured, non-interest bearing and due on demand. Amounts due to related parties consist of current and former executives, and a board member. In October 2022, the Company received advances from Trevor Pettennude totaling $325,000. The advances are unsecured, non-interest bearing and due on demand. The advances were paid off in September 2023. As of December 31, 2022, H&J had an outstanding note payable of $129,489 owned by the H&J Seller. The balance was $0 upon the H&J disposition in June 2023.

SHARE-BASED PAYMENTS

SHARE-BASED PAYMENTS	9 Months Ended
	Sep. 30, 2023
SHARE-BASED PAYMENTS
SHARE-BASED PAYMENTS	NOTE 10: SHARE-BASED PAYMENTS Common Stock Warrants In connection with the January Private Placement, the Company granted 32,085 pre-funded warrants which were immediately exercised for shares of common stock. The Company also granted an additional 51,085 warrants as part of the offering. Each warrant has an exercise price of $9.43 per share, is immediately exercisable upon issuance and expires five years after issuance. The Company also granted the placement agent 3,831 warrants to purchase common stock at an exercise price of $122.35 per share, which is immediately exercisable upon issuance and expires five years In connection with merchant advances (Note 6), the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25. The warrants are immediately exercisable upon issuance and expire five years after issuance. In connection with the August Private Placement, the Company granted 481,875 pre-funded warrants, which had not yet been exercised for shares of common stock as of September 30, 2023. These warrants are expected to be fully sold and exercised into shares in the fourth quarter of 2023. The Company also granted an additional 1,027,750 warrants as part of the offering. Each warrant has an exercise price of $9.43 per share, is immediately exercisable upon issuance and expires 5.5 years after issuance. The Company also granted the placement agent 38,541 warrants to purchase common stock at an exercise price of $12.16 per share, which is immediately exercisable upon issuance and expires 5.5 years after issuance. In connection with the August Private Placement, the Company entered into a warrant amendment (the “Warrant Amendment”) with certain investors to amend certain existing warrants to purchase up to 196,542 shares of Common Stock that were previously issued in December 2022 and January 2023 to the investors, with an exercise price of $131.25 per share and $95.00 per share, respectively (the “Amended Warrants”) as follows: (i) to reduce the exercise price of the Amended Warrants to $9.43 per share, and (ii) to extend the original expiration date of the Amended Warrants so that they will terminate five one half The following is a summary of warrant activity: ​ ​ ​ ​ ​ ​ ​ ​ Common Weighted ​ ​ Stock ​ Average ​ ​ Warrants ​ Exercise Price Outstanding - December 31, 2022 ​ 176,733 ​ $ 209.25 Granted ​ 1,641,262 ​ 14.69 Exercised ​ (155,899) ​ ​ 27.63 Forfeited ​ — ​ — Outstanding - September 30, 2023 ​ 1,662,096 ​ $ 20.86 Exercisable at December 31, 2022 ​ 171,278 ​ $ 210.50 Exercisable at September 30, 2023 1,662,096 ​ $ 26.19 ​ Stock Options As of September 30, 2023 and December 31, 2022, the Company had 1,558 stock options outstanding with a weighted average exercise price of $9,055.50 per share. As of September 30, 2023, there were 1,463 options exercisable. Stock-based compensation expense of $101,417 and $110,092 was recognized for the three months ended September 30, 2023 and 2022, respectively, and $308,511 and $368,944 was recognized for the nine months September 30, 2023 and 2022, respectively. During the nine months ended September 30, 2023 and 2022, $43,197 and $43,196 was recorded to sales and marketing expense, and all other stock compensation was included in general and administrative expense in the condensed consolidated statements of operations. Total unrecognized compensation cost related to non-vested stock option awards as of September 30, 2023 amounted to $269,490 and will be recognized over a weighted average period of 0.77 years.

LEASE OBLIGATIONS

LEASE OBLIGATIONS	9 Months Ended
	Sep. 30, 2023
LEASE OBLIGATIONS
LEASE OBLIGATIONS	NOTE 11: LEASE OBLIGATIONS In January 2023, the Company entered into a lease agreement extension for its corporate office and distribution center in Vernon, California that expires on December 31, 2023. The lease has monthly base rent payments of $38,105. As a result of the extension, the Company recognized a right of use asset and liability of $467,738 using a discount rate of 8.0%. As of September 30, 2023, the Company has $980,322 in accounts payable for past rents due to the landlord pertaining to this lease. In May 2023, the Company entered into a lease agreement extension for a showroom space in Los Angeles, California that commences in March 2023 and expires in January 2025. The original lease began in April 2018 and terminated in May 2020, at which point the lease was month to month. The lease has a monthly base rent of $6,520 until January 31, 2025, at which point the base rent increases to $6,781 until the end of the lease. As a result of the extension, the Company recognized a right of use asset and liability of $125,397 using a discount rate of 8.0%. As of September 30, 2023, the Company has $248,734 in accounts payable for past rents due to the landlord pertaining to this lease. Stateside and Sundry utilize a lease for a showroom in Los Angeles, California which is month to month. Total rent expense for the three months ended September 30, 2023 and 2022 was $140,304 and $267,041, and $401,444 and $736,523 for the nine months end June 30, 2023 and 2022, respectively.

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
CONTINGENCIES
CONTINGENCIES	NOTE 12: CONTINGENCIES On March 21, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $43,501. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On February 7, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $182,400. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On November 9, 2022, a vendor filed a lawsuit against Digital Brand’s Group related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $50,190. The matter was settled in January 2023 and are on payment plans which will be paid off in April 2023. In August 2020 and March 2021, two lawsuits were filed against Bailey’s by third-party’s related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $96,900. Both matters were settled in February 2022 and are on payment plans which will be paid off in July and September of 2023. On December 21, 2020, a Company investor filed a lawsuit against DBG for reimbursement of their investment totaling $100,000. Claimed amounts are included in short-term convertible note payable in the accompanying consolidated balance sheets and the Company does not believe it is probable that losses in excess of such short-term note payable will be incurred. The Company is actively working to resolve this matter. A vendor filed a lawsuit against Bailey 44 related to a retail store lease in the amount of $1.5 million. The Company is disputing the claim for damages and the matter is ongoing. The vendor has recently updated the claim to now be $450,968 after signing a long-term lease with another brand for this location. The Company is disputing this new amount after review of the lease. All claims above, to the extent management believes it will be liable, have been included in accounts payable and accrued expenses and other liabilities in the accompanying consolidated balance sheet as of September 30, 2023. Except as may be set forth above the Company is not a party to any legal proceedings, and the Company is not aware of any claims or actions pending or threatened against us. In the future, the Company might from time to time become involved in litigation relating to claims arising from its ordinary course of business, the resolution of which the Company does not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2023
INCOME TAXES
INCOME TAXES	NOTE 13: INCOME TAXES ​ The Company has historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pretax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. The Company has used a discrete effective tax rate method to calculate taxes for the fiscal three and nine month periods ended September 30, 2023. The Company determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the fiscal three and nine-month periods ended September 30, 2023. The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due, cumulative losses through September 30, 2023, and no history of generating taxable income.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 14: SUBSEQUENT EVENTS ​ Through the issuance date, the Company has exercised 225,375 pre-funded warrants per the August Prive Placement into shares of common stock. ​ ​

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”).
Reverse Stock Split	Reverse Stock Split On October 21, 2022, the Board of Directors approved a one
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of September 30, 2023, the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022, statements of changes in stockholders’ equity (deficit) and of cash flows for the nine months ended September 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ended December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K filed with SEC on April 17, 2023.
Principles of Consolidation	Principles of Consolidation These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J and Stateside from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J (see Note 4).
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, inventory, impairment of long-lived assets, contingent consideration and derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Reclassification of Previously Issued Financial Statements	Reclassification of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified $916,693 in general and administrative expenses per previously reported financial statements to net revenues in the accompanying consolidated statements of operations for the nine months ended September 30, 2022. The reclassified costs from general and administrative expense to cost of net revenues are primarily personnel and warehouse related costs. The reclassification had no effect on the reported results of operations. Certain prior year accounts have been reclassified to conform with current year presentation regarding income (loss) from discontinued operations. H&J’s assets and liabilities as of December 31, 2022 have also been reclassified on the consolidated balance sheet. See Note 4.
Cash and Equivalents and Concentration of Credit Risk	Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than three months to be cash equivalents. As of September 30, 2023 and December 31, 2022, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued expenses, due to related parties, related party note payable, and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ​ ​ as of September 30, 2023 Using: ​ Level 1 Level 2 Level 3 Total Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contingent consideration ​ $ — ​ $ — ​ $ — ​ $ — ​ ​ $ — ​ $ — ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ​ ​ as of December 31, 2022 Using: ​ Level 1 Level 2 Level 3 Total Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contingent consideration ​ $ — ​ $ — ​ $ 12,098,475 ​ $ 12,098,475 ​ ​ $ — ​ $ — ​ $ 12,098,475 ​ $ 12,098,475 ​ Contingent Consideration The Company recorded a contingent consideration liability relating to stock price guarantees included in its acquisitions of Bailey44 and H&J. The estimated fair value of the contingent consideration was recorded using significant unobservable measures and other fair value inputs and was therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. The fair value of the contingent consideration liability related to the Company’s business combinations is valued using the Monte Carlo simulation model. The Monte Carlo simulation inputs include the stock price, volatility of common stock, timing of settlement and resale restrictions and limits. The fair value of the contingent consideration is then calculated based on guaranteed equity values at settlement as defined in the acquisition agreements. Norwest Waiver On June 21, 2023, the Company, on the one hand, and Norwest Venture Partners XI, LP and Norwest Venture Partners XII, LP (together, the “Norwest Investors”), on the other hand, executed a Waiver and Amendment (the “Norwest Amendment”) whereby the Norwest Investors agreed to waive and terminate certain true up rights of the Norwest Investors under the Agreement and Plan of Merger, dated February 12, 2020 (the “Bailey Merger Agreement”), among the Company, Bailey 44, LLC, Norwest Venture Partners XI, LP, and Norwest Venture Partners XII, LP and Denim.LA Acquisition Corp. This transaction is known as the “Norwest Waiver”. As a result of the Norwest Waiver, the Company recorded a fair value of $0 pertaining to the contingent consideration contemplated under the Bailey Merger Agreement, resulting in a gain in the change in fair value of contingent consideration of $10,698,475. H&J Settlement Agreement On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby the Company transferred 100% of its membership interests in H&J to D. Jones (the “H&J Seller”). Pursuant to the Settlement Agreement, the Company agreed to make an aggregate cash payment of $229,000 to the H&J Seller and the Company issued 1,952,580 shares of common stock to the H&J Seller. In connection with the Settlement Agreement, the parties agreed that no further shares were owed to the H&J Seller resulting from the stock price guarantee pursuant to the May 2021 H&J acquisition. As a result, the Company recorded a fair value of $0 pertaining to the H&J contingent consideration, resulting in a gain in the change in fair value of contingent consideration of $1,400,000. The change in fair value was included in loss from discontinued operations in the consolidated statements of operations. See Note 4 for further detail. The detail of contingent consideration by company is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2023 2022 Bailey $ — ​ $ 10,698,475 Harper & Jones ​ — ​ 1,400,000 ​ ​ $ — ​ $ 12,098,475 ​
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of September 30, 2023 and December 31, 2022 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process ​ 653,412 ​ 888,643 Finished goods ​ 2,548,499 ​ 2,622,787 Inventory ​ $ 4,710,327 ​ $ 5,122,564
Goodwill	​ Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required.
Annual Impairment	Annual Impairment At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and H&J may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations during the year ended December 31, 2022. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 pertaining to goodwill in the consolidated statements of operations during the year ended December 31, 2022.
Net Loss per Share	Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. The following table sets forth the a) the dilutive items included in the weighted average common shares – diluted amount above as of September 30, 2023 and b) the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ 2023 2022 Convertible notes — 47,092 Series A convertible preferred stock ​ 27,097 ​ 27,097 Series C convertible preferred stock ​ 321,395 ​ — Common stock warrants 1,662,096 ​ 5,285 Stock options 1,558 ​ 1,558 Total potentially dilutive shares 2,012,145 ​ 81,032 ​ The stock options and warrants above are out-of-the-money as of September 30, 2023 and 2022.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which amends and clarifies several provisions of Topic 326. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief, which amends Topic 326 to allow the fair value option to be elected for certain financial instruments upon adoption. ASU 2019-10 extended the effective date of ASU 2016-13 until December 15, 2022. The Company adopted this new guidance, including the subsequent updates to Topic 326, on January 1, 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are
Unaudited Pro Forma Financial Information, Policy	Unaudited Pro Forma Financial Information The following unaudited pro forma financial information presents the Company’s financial results as if the Sundry acquisition had occurred as of January 1, 2022. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The following unaudited pro forma financial information includes incremental property and equipment depreciation and intangible asset amortization as a result of the acquisitions. The pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition: ​ ​ ​ ​ ​ ​ Nine Months Ended ​ ​ September 30, ​ ​ 2022 Net revenues ​ $ 23,995,555 Net loss ​ $ (8,405,222) Net loss per common share ​ $ (29.63) ​

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of financial assets and liabilities measured at fair value on recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ​ ​ as of September 30, 2023 Using: ​ Level 1 Level 2 Level 3 Total Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contingent consideration ​ $ — ​ $ — ​ $ — ​ $ — ​ ​ $ — ​ $ — ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ​ ​ as of December 31, 2022 Using: ​ Level 1 Level 2 Level 3 Total Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contingent consideration ​ $ — ​ $ — ​ $ 12,098,475 ​ $ 12,098,475 ​ ​ $ — ​ $ — ​ $ 12,098,475 ​ $ 12,098,475
Summary of contingent consideration	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2023 2022 Bailey $ — ​ $ 10,698,475 Harper & Jones ​ — ​ 1,400,000 ​ ​ $ — ​ $ 12,098,475
Schedule of inventory	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process ​ 653,412 ​ 888,643 Finished goods ​ 2,548,499 ​ 2,622,787 Inventory ​ $ 4,710,327 ​ $ 5,122,564
Schedule of potentially dilutive items outstanding	​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ 2023 2022 Convertible notes — 47,092 Series A convertible preferred stock ​ 27,097 ​ 27,097 Series C convertible preferred stock ​ 321,395 ​ — Common stock warrants 1,662,096 ​ 5,285 Stock options 1,558 ​ 1,558 Total potentially dilutive shares 2,012,145 ​ 81,032
Schedule of business acquisition pro forma information	​ ​ ​ ​ ​ ​ Nine Months Ended ​ ​ September 30, ​ ​ 2022 Net revenues ​ $ 23,995,555 Net loss ​ $ (8,405,222) Net loss per common share ​ $ (29.63) ​

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Sep. 30, 2023
DISCONTINUED OPERATIONS
Schedule of components of disposition	The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J. The components of the disposition are as follows: ​ ​ ​ ​ Cash payment due to H&J Seller $ (229,000) Common shares issued to H&J Seller* ​ (1,357,043) Total fair value of consideration received (given) ​ $ (1,586,043) ​ ​ ​ ​ Carrying amount of assets and liabilities ​ Cash and cash equivalents ​ 18,192 Accounts receivable, net ​ 55,782 Prepaid expenses and other current assets ​ 25,115 Goodwill ​ 1,130,311 Intangible assets, net ​ 1,246,915 Deposits ​ 4,416 Accounts payable ​ (40,028) Accrued expenses and other liabilities ​ (734,068) Deferred revenue ​ (18,347) Due to related parties ​ (1,008) Contingent consideration ​ ​ (1,400,000) Loan payable ​ (219,894) Note payable - related party ​ (129,489) Total carrying amount of assets and liabilities ​ (62,103) ​ ​ ​ ​ Loss on disposition of business ​ $ (1,523,940) *Represents the fair value of 1,952,580 shares of common stock issued to D. Jones. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Nine Months Ended ​ ​ September 30, ​ September 30, ​ ​ 2023 2022 ​ 2023 2022 Net revenues ​ $ — ​ $ 765,678 ​ $ 1,405,482 ​ $ 2,658,527 Cost of net revenues ​ — ​ 356,349 ​ 565,621 ​ 961,761 Gross profit ​ — ​ 409,329 ​ 839,861 ​ 1,696,765 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Operating expenses: ​ ​ ​ ​ ​ ​ ​ ​ General and administrative ​ — ​ 359,205 ​ 520,582 ​ 1,256,078 Sales and marketing ​ — ​ 203,087 ​ 346,167 ​ 718,862 Distribution ​ — ​ — ​ — ​ — Change in fair value of contingent consideration ​ — ​ — ​ — ​ — Total operating expenses ​ — ​ 562,293 ​ 866,749 ​ 1,974,940 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Loss from operations ​ — ​ (152,962) ​ (26,888) ​ (278,175) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ Interest expense ​ — ​ (7,470) ​ (11,675) ​ (48,332) Loss on disposition of business ​ — ​ — ​ (1,523,940) ​ — Other non-operating income (expenses) ​ — ​ — ​ — ​ — Total other income (expense), net ​ — ​ (7,470) ​ (1,535,615) ​ (48,332) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Income tax benefit (provision) ​ — ​ — ​ — ​ — Net loss from discontinued operations ​ $ — ​ $ (160,432) ​ $ (1,562,503) ​ $ (326,507) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average common shares outstanding – basic and diluted ​ 373,498 ​ 21,150 ​ 283,673 ​ 9,836 Net loss from discontinued operations per common share – basic and diluted ​ $ — ​ $ (7.59) ​ $ (5.51) ​ $ (33.19) ​

DUE FROM FACTOR (Tables)

DUE FROM FACTOR (Tables)	9 Months Ended
	Sep. 30, 2023
DUE FROM FACTOR
Schedule of due to/ from factor	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Outstanding receivables: ​ ​ ​ ​ ​ ​ Without recourse ​ $ 308,918 ​ $ 1,680,042 With recourse ​ 29,843 ​ 65,411 Matured funds and deposits ​ ​ 103,095 ​ ​ 81,055 Advances ​ ​ (172,285) ​ ​ (632,826) Credits due customers ​ ​ (10,746) ​ ​ (354,282) ​ ​ $ 258,825 ​ $ 839,400 ​

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2023
GOODWILL AND INTANGIBLE ASSETS
Schedule of goodwill attributable to each business combination	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31 ​ ​ 2023 ​ 2022 Bailey ​ $ 3,158,123 ​ $ 3,158,123 Stateside ​ 2,104,056 ​ 2,104,056 Sundry ​ 3,711,322 ​ 3,711,322 ​ ​ $ 8,973,501 ​ $ 8,973,501
Schedule of information relating to the Company's identifiable intangible assets	The following table summarizes information relating to the Company’s identifiable intangible assets as of September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Accumulated Carrying ​ ​ Amount ​ Amortization ​ Value Amortized: ​ ​ ​ Customer relationships ​ $ 9,734,560 ​ $ (4,874,676) ​ $ 4,859,884 ​ ​ $ 9,734,560 ​ $ (4,874,676) ​ $ 4,859,884 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Indefinite-lived: ​ ​ ​ ​ ​ ​ Brand name ​ $ 5,841,880 ​ ​ — ​ 5,841,880 ​ ​ $ 15,576,440 ​ $ (4,874,676) ​ $ 10,701,764

LIABILITIES AND DEBT (Tables)

LIABILITIES AND DEBT (Tables)	9 Months Ended
	Sep. 30, 2023
LIABILITIES AND DEBT
Schedule of accrued expenses and other liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Accrued expenses ​ $ 489,628 ​ $ 668,714 Reserve for returns ​ — ​ 307,725 Payroll related liabilities ​ 3,792,438 ​ 2,618,870 Sales tax liability ​ 304,748 ​ 262,765 Other liabilities ​ 194,817 ​ 78,845 ​ ​ $ 4,781,632 ​ $ 3,936,920
Schedule of the convertible notes	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Unamortized Convertible Note ​ ​ Principal ​ Debt Discount ​ Payable, Net Balance, December 31, 2022 ​ $ 4,100,000 ​ $ (1,378,200) ​ $ 2,721,800 Repayments of notes ​ (4,000,000) ​ — ​ (4,000,000) Amortization of debt discount ​ — ​ 689,100 ​ 689,100 Loss on extinguishment of debt ​ — ​ 689,100 ​ 689,100 Balance, September 30, 2023 ​ $ 100,000 ​ $ — ​ $ 100,000
Schedule of promissory notes payable, net	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2023 ​ 2022 Bailey Note ​ $ 3,500,000 ​ $ 3,500,000 Sundry Note ​ — ​ 5,500,000 March 2023 Notes - principal ​ 1,399,018 ​ — Promissory note payable, net ​ $ 4,899,018 ​ $ 9,000,000 ​

SHARE-BASED PAYMENTS (Tables)

SHARE-BASED PAYMENTS (Tables)	9 Months Ended
	Sep. 30, 2023
SHARE-BASED PAYMENTS
Summary of information related to common stock and preferred stock warrants	​ ​ ​ ​ ​ ​ ​ ​ Common Weighted ​ ​ Stock ​ Average ​ ​ Warrants ​ Exercise Price Outstanding - December 31, 2022 ​ 176,733 ​ $ 209.25 Granted ​ 1,641,262 ​ 14.69 Exercised ​ (155,899) ​ ​ 27.63 Forfeited ​ — ​ — Outstanding - September 30, 2023 ​ 1,662,096 ​ $ 20.86 Exercisable at December 31, 2022 ​ 171,278 ​ $ 210.50 Exercisable at September 30, 2023 1,662,096 ​ $ 26.19

NATURE OF OPERATIONS (Details)

NATURE OF OPERATIONS (Details) - USD ($)		3 Months Ended
	Jun. 21, 2023	Jun. 30, 2023	Dec. 30, 2022	Aug. 30, 2021	May 18, 2021
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
D.Jones (H&J Seller) | H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580	1,952,580
Percentage of membership interest transferred	100%
D.Jones (H&J Seller) | Harper & Jones, LLC | H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580
D.Jones (H&J Seller) | Disposal group, Disposed by sale | Harper & Jones, LLC | H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580
Percentage of membership interest transferred	100%
Harper & Jones
NATURE OF OPERATIONS
Percentage of equity acquired					100%
Stateside
NATURE OF OPERATIONS
Percentage of equity acquired				100%
Sundry
NATURE OF OPERATIONS
Percentage of equity acquired			100%

GOING CONCERN (Details)

GOING CONCERN (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
GOING CONCERN
Net loss	$ 6,528,082	$ 22,261,338
Working capital deficit	$ 14,709,598

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)				3 Months Ended		9 Months Ended
	Aug. 21, 2023	Jun. 21, 2023 USD ($) shares	Oct. 21, 2022	Jun. 30, 2023 shares	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reverse stock split conversion ratio	0.25		0.01
Reclassification adjustment							$ 916,693
Cash and cash equivalents in bank deposit						$ 250,000
Fair value of contingent consideration								$ 12,098,475
Gain in the change in fair value of contingent consideration					$ (702,885)	$ (10,698,475)	$ 6,418,355
Aggregate cash payment agreed to pay		$ 229,000
Bailey LLC
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration								$ 10,698,475
Norwest investors | Norwest waiver | Bailey LLC
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration		0
Gain in the change in fair value of contingent consideration		10,698,475
D.Jones (H&J Seller) | H&J Settlement Agreement
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration		0
Gain in the change in fair value of contingent consideration		1,400,000
Aggregate cash payment agreed to pay		$ 229,000
Issuance of common stock pursuant to disposition (in shares) | shares		1,952,580		1,952,580
Percentage of membership interest transferred		100%

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Liabilities:
Fair value of contingent consideration	$ 12,098,475
Total	12,098,475
Level 3
Liabilities:
Fair value of contingent consideration	12,098,475
Total	12,098,475
Harper & Jones, LLC
Liabilities:
Fair value of contingent consideration	1,400,000
Bailey LLC
Liabilities:
Fair value of contingent consideration	$ 10,698,475

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Raw materials	$ 1,508,416	$ 1,611,134
Work in process	653,412	888,643
Finished goods	2,548,499	2,622,787
Inventory	$ 4,710,327	$ 5,122,564

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Impairment loss of consolidated statements of operations	$ 3,667,000
Impairment of goodwill	$ 11,872,332

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss per Share (Details) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Potentially dilutive items outstanding
Total potentially dilutive shares	2,012,145	81,032
Stock options
Potentially dilutive items outstanding
Total potentially dilutive shares	1,558	1,558
Convertible notes
Potentially dilutive items outstanding
Total potentially dilutive shares		47,092
Series A convertible preferred stock
Potentially dilutive items outstanding
Total potentially dilutive shares	27,097	27,097
Series C convertible preferred stock
Potentially dilutive items outstanding
Total potentially dilutive shares	321,395
Common stock warrants
Potentially dilutive items outstanding
Total potentially dilutive shares	1,662,096	5,285

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Unaudited Pro Forma Financial Information (Details)	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Net revenues | $	$ 23,995,555
Net loss | $	$ (8,405,222)
Net loss per common share , Basic | $ / shares	$ (29.63)
Net loss per common share , Diluted | $ / shares	$ (29.63)

DISCONTINUED OPERATIONS - Busin

DISCONTINUED OPERATIONS - Business disposition (Details) - USD ($)		3 Months Ended	9 Months Ended
	Jun. 21, 2023	Jun. 30, 2023	Sep. 30, 2023
DISCONTINUED OPERATIONS
Cash payment due to H&J Seller	$ (229,000)
Common shares issued to H&J Seller*	(1,357,043)	$ (1,357,043)
Total fair value of consideration received (given)	(1,586,043)
Carrying amount of assets and liabilities
Cash and cash equivalents	18,192
Accounts receivable, net	55,782
Prepaid expenses and other current assets	25,115
Goodwill	1,130,311
Intangible assets, net	1,246,915
Deposits	4,416
Accounts payable	(40,028)
Accrued expenses and other liabilities	(734,068)
Deferred revenue	(18,347)
Due to related parties	(1,008)
Contingent consideration	(1,400,000)
Loan payable	(219,894)
Note payable - related party	(129,489)
Total carrying amount of assets and liabilities	(62,103)
Loss on disposition of business	(1,523,940)		$ (1,523,940)
Disposal group, Disposed by sale
Carrying amount of assets and liabilities
Loss on disposition of business	$ 1,523,940
Harper & Jones, LLC | Disposal group, Disposed by sale
Carrying amount of assets and liabilities
Goodwill			1,130,311
Intangible assets, net			$ 1,246,915

DISCONTINUED OPERATIONS - Addit

DISCONTINUED OPERATIONS - Additional information (Details) - USD ($)		3 Months Ended	9 Months Ended
	Jun. 21, 2023	Jun. 30, 2023	Sep. 30, 2023
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Loss on disposition of business	(1,523,940)		$ (1,523,940)
H&J Settlement Agreement | D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580	1,952,580
Percentage of membership interest transferred	100%
Disposal group, Disposed by sale
DISCONTINUED OPERATIONS
Loss on disposition of business	$ 1,523,940
Harper & Jones, LLC | H&J Settlement Agreement | D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580
Harper & Jones, LLC | Disposal group, Disposed by sale | H&J Settlement Agreement | D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	1,952,580
Percentage of membership interest transferred	100%
Payments made			200,000
Remaining consideration payable			$ 29,000

DISCONTINUED OPERATIONS - Conso

DISCONTINUED OPERATIONS - Consolidated statements of operations of discontinued operations of HJ (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
DISCONTINUED OPERATIONS
Net revenues	$ 3,257,332	$ 2,658,844	$ 12,127,135	$ 7,937,406
Cost of net revenues	1,554,044	1,700,547	6,094,532	5,252,943
Gross profit	1,703,288	958,298	6,032,603	2,684,464
Operating expenses:
General and administrative	3,735,527	2,979,915	12,115,590	11,053,536
Sales and marketing	1,151,377	1,022,331	3,188,054	3,252,418
Distribution	238,546	97,737	750,945	522,510
Change in fair value of contingent consideration		(702,885)	(10,698,475)	6,418,355
Total operating expenses	5,125,450	3,397,098	5,356,114	21,246,820
Income (loss) from operations	(3,422,162)	(2,438,800)	676,489	(18,562,356)
Other income (expense):
Interest expense	(1,956,080)	(2,271,548)	(4,907,567)	(6,002,160)
Other non-operating income (expenses)	(57,752)	(23,690)	(734,501)	2,629,685
Total other income (expense), net	$ (2,013,832)	(2,295,238)	(5,642,068)	(3,372,475)
Net loss from discontinued operations		$ (160,433)	$ (1,562,503)	$ (326,507)
Weighted average common shares outstanding - basic	373,498	21,150	283,673	13,649
Weighted average common shares outstanding -diluted	373,498	21,150	283,673	13,649
Harper & Jones, LLC
DISCONTINUED OPERATIONS
Net revenues		$ 765,678	$ 1,405,482	$ 2,658,527
Cost of net revenues		356,349	565,621	961,761
Gross profit		409,329	839,861	1,696,765
Operating expenses:
General and administrative		359,205	520,582	1,256,078
Sales and marketing		203,087	346,167	718,862
Total operating expenses		562,293	866,749	1,974,940
Income (loss) from operations		(152,962)	(26,888)	(278,175)
Other income (expense):
Interest expense		(7,470)	(11,675)	(48,332)
Loss on disposition of business	$ 0		(1,523,940)
Total other income (expense), net		(7,470)	(1,535,615)	(48,332)
Net loss from discontinued operations		$ (160,432)	$ (1,562,503)	$ (326,507)
Weighted average common shares outstanding - basic	373,498	21,150	283,673	9,836
Weighted average common shares outstanding -diluted	373,498	21,150	283,673	9,836
Net loss from discontinued operations per common share - basic		$ (7.59)	$ (5.51)	$ (33.19)
Net loss from discontinued operations per common share - diluted		$ (7.59)	$ (5.51)	$ (33.19)

DUE FROM FACTOR (Details)

DUE FROM FACTOR (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Outstanding receivables:
Without recourse	$ 308,918	$ 1,680,042
With recourse	29,843	65,411
Matured funds and deposits	103,095	81,055
Advances	172,285	632,826
Credits due customers	(10,746)	(354,282)
Due from factor	$ 258,825	$ 839,400

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Summary of goodwill by entity (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
GOODWILL AND INTANGIBLE ASSETS
Goodwill	$ 8,973,501	$ 8,973,501
Bailey
GOODWILL AND INTANGIBLE ASSETS
Goodwill	3,158,123	3,158,123
Stateside
GOODWILL AND INTANGIBLE ASSETS
Goodwill	2,104,056	2,104,056
Sundry
GOODWILL AND INTANGIBLE ASSETS
Goodwill	$ 3,711,322	$ 3,711,322

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 21, 2023	Dec. 31, 2022
Indefinite-lived Intangible Assets
Gross Amount	$ 9,734,560		$ 9,734,560
Accumulated Amortization	(4,874,676)		(4,874,676)
Carrying Value	4,859,884		4,859,884
Indefinite-lived	15,576,440		15,576,440
Intangible assets, net	10,701,764		10,701,764			$ 12,906,238
Intangible assets					$ 1,246,915
Amortization expense	719,547	$ 537,813	2,478,824	$ 1,613,438
Goodwill					$ 1,130,311
Harper & Jones, LLC | Disposal group, Disposed by sale
Indefinite-lived Intangible Assets
Intangible assets	1,246,915		1,246,915
Goodwill	1,130,311		1,130,311
Customer relationships
Indefinite-lived Intangible Assets
Gross Amount	9,734,560		9,734,560
Accumulated Amortization	(4,874,676)		(4,874,676)
Carrying Value	4,859,884		4,859,884
Brand name
Indefinite-lived Intangible Assets
Indefinite-lived	$ 5,841,880		$ 5,841,880

LIABILITIES AND DEBT - Accrued

LIABILITIES AND DEBT - Accrued Expenses and Other Liabilities (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
Accrued expenses	$ 489,628	$ 668,714
Reserve for returns		307,725
Payroll related liabilities	3,792,438	2,618,870
Sales tax liability	304,748	262,765
Other liabilities	194,817	78,845
Accrued expenses and other liabilities, Total	4,781,632	3,936,920
Estimated penalties associated with accrued payroll taxes	1,406,403
Accrued expenses included in accrued common stock	$ 535,000	$ 535,000
Number of common shares owed per the agreement	200
DBG
LIABILITIES AND DEBT
Sales tax liability	$ 698,842
Bailey
LIABILITIES AND DEBT
Sales tax liability	$ 707,561

LIABILITIES AND DEBT - Converti

LIABILITIES AND DEBT - Convertible Debt (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Convertible Debt 2020 Regulation D Offering
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO	$ 100,000	$ 100,000

LIABILITIES AND DEBT - Conver_2

LIABILITIES AND DEBT - Convertible Promissory Note (Details) - USD ($)			1 Months Ended		3 Months Ended		9 Months Ended
	May 30, 2023	Dec. 29, 2022	Feb. 28, 2023	Jan. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Aug. 31, 2023
LIABILITIES AND DEBT
Warrants exercise price					$ 9.43		$ 9.43		$ 131.25
Issuance of Series A preferred stock (in shares)							1,277,140
Repayments of debt							$ 8,840,092	$ 3,068,750
Loss on extinguishment of debt							(689,100)
Issuance of Series A preferred stock	$ 25,000				$ 3,832,305	$ 4,463,076
Promissory note
LIABILITIES AND DEBT
Issuance of Series A preferred stock (in shares)				110,000
Issuance of Series A preferred stock				$ 322,300
Promissory note
LIABILITIES AND DEBT
Amortization of debt discount							689,100	$ 1,792,060
Shares issued to notes payable holders								350
Outstanding principal amount converted								$ 888,930
Repayments of notes
LIABILITIES AND DEBT
Repayments of notes							$ (4,000,000)
December Notes | Securities purchase agreement
LIABILITIES AND DEBT
Aggregate principal amount		$ 4,000,000
Original issue discount		800,000
Net proceeds		$ 3,000,000
Percentage of increase in face value		120%
Percentage of annual interest rate		20%
Number of warrants issued to purchase common stock					469,480		469,480
Warrants exercise price					$ 4.26		$ 4.26
Issuance of Series A preferred stock (in shares)							60,000
Debt discount for the fair value of the warrants					$ 428,200		$ 428,200
Unamortized debt discount					1,378,200		1,378,200
Repayments of debt			$ 4,000,000
Amortization of debt discount			689,100
Loss on extinguishment of debt			$ 689,100
Unamortized Debt Discount, ending balance					1,378,200		1,378,200
Convertible Promissory Note
LIABILITIES AND DEBT
Unamortized debt discount
Principal, beginning balance				4,100,000		4,100,000	4,100,000
Unamortized Debt Discount, beginning balance				1,378,200		1,378,200	1,378,200
Convertible Note Payable, Net beginning balance				$ 2,721,800		$ 2,721,800	2,721,800
Amortization of debt discount							689,100
Loss on extinguishment of debt							689,100
Principal, ending balance					100,000		100,000
Convertible Note Payable, Net ending balance					$ 100,000		$ 100,000

LIABILITIES AND DEBT - Loan Pay

LIABILITIES AND DEBT - Loan Payable - PPP and SBA Loan (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
PPP Loan | Bailey LLC
LIABILITIES AND DEBT
Convertible note payable, net	$ 933,295	$ 933,295

LIABILITIES AND DEBT- Merchant

LIABILITIES AND DEBT- Merchant Advances (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Aug. 31, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
Exercise price per share	$ 9.43	$ 131.25
Merchant Advance from Shopify Capital
LIABILITIES AND DEBT
Secured Debt	$ 506,728
Proceeds from debt	902,051
Repayments	395,323
Merchant Advances
LIABILITIES AND DEBT
Secured Debt	438,000		$ 896,334
Net proceeds	2,880,238
Repayments of debt	$ 3,338,572
Warrants issued	6,095
Exercise price per share	$ 131.25

LIABILITIES AND DEBT - Promisso

LIABILITIES AND DEBT - Promissory Note Payable (Details) - USD ($)		1 Months Ended	3 Months Ended			6 Months Ended	9 Months Ended
	Jun. 21, 2023	Mar. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Feb. 15, 2023	Dec. 31, 2022
Debt Instrument
Promissory note payable, net			$ 4,899,018				$ 4,899,018			$ 9,000,000
Fair value per share		$ 4.20
Common Stock
Debt Instrument
Shares issued to notes payable holders							32,000
Securities purchase agreement | Series C convertible preferred stock
Debt Instrument
Shares issued to notes payable holders	5,761
Fair value per share	$ 1,000
Bailey Note
Debt Instrument
Aggregate principal amount			3,500,000				$ 3,500,000			3,500,000
Interest expense			105,000		$ 105,000		315,000	$ 315,000
Promissory note payable, net			3,500,000				3,500,000			3,500,000
Sundry Note
Debt Instrument
Interest expense				$ 149,177		$ 259,177
Promissory note payable, net			5,500,000				5,500,000			$ 5,500,000
Promissory note, annual interest rate (as a percent)									8%
Sundry Note | Securities purchase agreement
Debt Instrument
Cancellation of principal amount							5,500,000
Accrued interest converted							259,177
Sundry Note | Securities purchase agreement | Series C convertible preferred stock
Debt Instrument
Shares issued to notes payable holders	5,761
Fair value per share	$ 1,000
March 2023 Notes
Debt Instrument
Promissory note payable, net		$ 2,458,750	$ 1,399,018				$ 1,399,018
Original issue discount		608,750
Net proceeds		$ 1,850,000
Prepayment penalty			0%				0%
Percentage of notes to be repaid, if the Company completes a debt or equity financing of less than the threshold amount							$ 7,500,000
Percentage of notes to be repaid, if the Company completes a debt or equity financing of less than the threshold amount			50%				50%
Percentage of notes to be repaid, if the Company completes a debt or equity financing of amount equal to or greater than the threshold amount			100%				100%
Penalty percentage on notes to be repaid, if the Company completes a debt or equity financing of amount equal to or greater than the threshold amount			0%				0%
Additional interest percentage			0%				0%
Original interest discount percentage			20%				20%
Repayments of principal							$ 1,059,732
Amortization of debt discount							$ 608,750

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

Sep. 10, 2023

Aug. 31, 2023

Jun. 21, 2023

May 30, 2023

Jan. 11, 2023

Sep. 30, 2023

Mar. 31, 2023

Jan. 31, 2023

Sep. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Sep. 30, 2022

Sep. 30, 2023

Aug. 31, 2022

Class of Stock

Issuance of Series A preferred stock (in shares)

1,277,140

Issuance of Series A preferred stock

$ 25,000

$ 3,832,305

$ 4,463,076

Common stock issued for services

$ 499,338

$ 1,157,090

$ 499,338

Issue price (in dollars per share)

$ 4.20

$ 4.20

Share Price

$ 9.73

Net proceeds after deducting placement agent fees and offering expenses

$ 3,800,000

Number of warrants exercised

123,814

Warrants exercise price

$ 131.25

$ 9.43

$ 9.43

$ 9.43

Proceeds from exercise of warrants

$ 1,167,566

Value of stock issued for accrued amounts owed to Sundry executives

$ 500,000

Common stock issued for services (in shares)

118,890

Shares issued in accrued amounts owed to Sundry executives based on their employment agreements

42,782

Issuance of common stock pursuant to disposition

$ 1,357,043

$ 1,357,043

Aggregate net proceeds

$ 3,800,000

Exercise of warrants

$ 1,167,566

Share issued price

$ 9.73

John Hilburn Davis IV | Series A preferred stock

Class of Stock

Stated Value

$ 25,000

Preferred stock, shares outstanding (in shares)

250,000,000

Maximum

Class of Stock

Warrants termination period

5 years

5 years

5 years

Minimum

Class of Stock

Warrants termination period

1 year 6 months

1 year 6 months

1 year 6 months

Promissory note

Class of Stock

Issuance of Series A preferred stock (in shares)

110,000

Issuance of Series A preferred stock

$ 322,300

Common Stock

Class of Stock

Issuance of Series A preferred stock (in shares)

32,000

51,086

Issuance of Series A preferred stock

$ 3

$ 5

Common stock issued for services

$ 11

Warrants issued

481,875

Common stock issued for services (in shares)

105,174

4,756

Number of shares resulting from conversion

32,000

Gross proceeds

$ 5,000,000

Net proceeds

$ 4,300,000

Issuance of common stock pursuant to disposition (in shares)

78,103

Issuance of common stock pursuant to disposition

$ 8

Common stock issued pursuant to consulting agreement (in shares)

30

Common Warrant

Class of Stock

Warrants issued

475,000

Volume-Weighted Average

$ 3.915

Number of shares resulting from conversion

802,140

Common Warrant | Common Stock

Class of Stock

Issuance of Series A preferred stock (in shares)

475,000

Series A Warrants [Member]

Class of Stock

Warrants issued

481,875

Series B warrants

Class of Stock

Warrants issued

481,875

Pre-funded warrants

Class of Stock

Issuance of Series A preferred stock (in shares)

802,140

Warrants issued

802,140

Number of warrants exercised

0

Warrants exercise price

$ 9.43

$ 9.43

$ 9.43

Warrants termination period

5 years 6 months

5 years 6 months

5 years 6 months

Volume-Weighted Average

$ 3.915

Number of shares resulting from conversion

802,140

Number of warrants issued

481,875

Pre-funded warrants | Maximum

Class of Stock

Warrants termination period

5 years

5 years

5 years

Pre-funded warrants | Minimum

Class of Stock

Warrants termination period

1 year 6 months

1 year 6 months

1 year 6 months

H&J Settlement Agreement | D.Jones (H&J Seller)

Class of Stock

Issuance of common stock pursuant to disposition (in shares)

1,952,580

1,952,580

Issuance of common stock pursuant to disposition

$ 1,357,043

2023 Plan

Class of Stock

Term for non-recourse promissory notes

5 years

Common stock issued for services

$ 657,090

Issue price (in dollars per share)

$ 10.43

Aggregate number of common stock issuable

65,000

Common stock issued for services (in shares)

63,000

Private Placement

Class of Stock

Issuance of Series A preferred stock (in shares)

475,000

Share Price

$ 9.73

Proceeds from Issuance of Private Placement

$ 5,000,000

$ 5,000,000

Number of warrants amended

196,542

Warrants exercise price

$ 95

Reduce the exercise price of the Amended Warrants

9.43

Share issued price

$ 9.73

Private Placement | Series A Warrants [Member]

Class of Stock

Issuance of Series A preferred stock (in shares)

32,000

Private Placement | Series B warrants

Class of Stock

Number of warrants issued

32,000

STOCKHOLDERS' DEFICIT - Series

STOCKHOLDERS' DEFICIT - Series B Preferred Stock (Details) - USD ($)		3 Months Ended		9 Months Ended
	May 30, 2023	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Class of Stock
Issuance of Series A preferred stock (in shares)				1,277,140
Issuance of Series A preferred stock	$ 25,000	$ 3,832,305	$ 4,463,076
Common stock par value		$ 0.0001		$ 0.0001	$ 0.0001
Consideration upon redemption	$ 25,000
Series A preferred stock
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001
Series B Preferred Stock
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001
Number of votes per share	250,000,000
Series B Preferred Stock | Subscription Agreement | John Hilburn Davis IV
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001

STOCKHOLDERS' DEFICIT - Serie_2

STOCKHOLDERS' DEFICIT - Series C Convertible Preferred Stock (Details) - USD ($)	Jun. 21, 2023	Jun. 20, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Class of Stock
Issue price (in dollars per share)				$ 4.20
Series C convertible preferred stock
Class of Stock
Preferred stock, par value (in dollars per share)			$ 0.0001		$ 0.0001
Redemption percentage	112%
Series C convertible preferred stock | Securities purchase agreement
Class of Stock
Number of shares resulting from conversion	5,761
Preferred stock, par value (in dollars per share)	$ 0.0001
Issue price (in dollars per share)	$ 1,000
Convertible preferred stock value	$ 1,000
Conversion price (in dollars per share)	$ 0.717
Number of trading days	5 days	5 days

RELATED PARTY TRANSACTIONS - (D

RELATED PARTY TRANSACTIONS - (Details) - USD ($)	6 Months Ended	9 Months Ended
	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Oct. 31, 2022
RELATED PARTY TRANSACTIONS
Repayments from related parties		$ 218,967	$ 162,692
Due to related parties		$ 336,250		$ 556,225
Advances | Director
RELATED PARTY TRANSACTIONS
Advance due to related parties					$ 325,000
Notes Payable, Other Payables
RELATED PARTY TRANSACTIONS
Outstanding balance	$ 0
Notes Payable, Other Payables | H&J
RELATED PARTY TRANSACTIONS
Aggregate principal amount				$ 129,489

SHARE-BASED PAYMENTS - Common S

SHARE-BASED PAYMENTS - Common Stock Warrants - General Information (Details) - USD ($)		9 Months Ended
	Aug. 31, 2023	Sep. 30, 2023	Jan. 31, 2023	Jan. 11, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
Exercise price per share	$ 131.25	$ 9.43
Option outstanding exercise price (in dollars per share)		9,055.50			$ 9,055.50
Option outstanding exercise price		$ 9,055.50			$ 9,055.50
Weighted average duration (Years)		5 years
Number of awards granted		1,027,750
Number of warrants exercised	123,814
Proceeds from exercise of warrants	$ 1,167,566
Aggregate shares of stock options granted		51,085
Minimum
SHARE-BASED PAYMENTS
Warrants exercisable term		1 year 6 months
Maximum
SHARE-BASED PAYMENTS
Warrants exercisable term		5 years
Placement agent
SHARE-BASED PAYMENTS
Exercise price per share		$ 12.16
Number of awards granted		38,541
Pre-funded warrants
SHARE-BASED PAYMENTS
Warrants issued				802,140
Exercise price per share		$ 9.43
Number of awards granted		481,875
Warrants exercisable term		5 years 6 months
Number of warrants exercised	0
Aggregate shares of stock options granted		32,085
Pre-funded warrants | Minimum
SHARE-BASED PAYMENTS
Warrants exercisable term		1 year 6 months
Pre-funded warrants | Maximum
SHARE-BASED PAYMENTS
Warrants exercisable term		5 years
Pre-funded warrants | Placement agent
SHARE-BASED PAYMENTS
Warrants issued			196,542		196,542
Exercise price per share			$ 95		$ 131.25
Number of warrants exercised		123,814
Proceeds from exercise of warrants		$ 1,167,566
Placement Agent Warrant
SHARE-BASED PAYMENTS
Exercise price per share		$ 122.35
Weighted average duration (Years)		5 years
Aggregate shares of stock options granted		3,831
Placement Agent Warrant | Placement agent
SHARE-BASED PAYMENTS
Warrants exercisable term		5 years 6 months
Aggregate Warrant
SHARE-BASED PAYMENTS
Warrants issued		6,095
Exercise price of additional units		$ 131.25

SHARE-BASED PAYMENTS - Warrants

SHARE-BASED PAYMENTS - Warrants Roll Forward (Details) - Common stock warrants - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
Warrant Outstanding Beginning Balance	176,733
Granted	1,641,262
Exercised	(155,899)
Warrant Outstanding Ending Balance	1,662,096	176,733
Common Stock Warrants Exercisable	1,662,096	171,278
Weighted Average Exercise Price Outstanding Beginning Balance	$ 209.25
Granted	14.69
Exercised	27.63
Weighted Average Exercise Price Outstanding Ending Balance	20.86	$ 209.25
Weighted Average Exercise Price Exercisable	$ 26.19	$ 210.50

SHARE-BASED PAYMENTS - Stock-ba

SHARE-BASED PAYMENTS - Stock-based Compensation - Stock options granted (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
SHARE-BASED PAYMENTS
Option outstanding	1,558		1,558		1,558
Option outstanding exercise price (in dollars per share)	$ 9,055.50		$ 9,055.50		$ 9,055.50
Option exercisable	1,463		1,463
Stock-based compensation expense	$ 101,417	$ 110,092	$ 308,511	$ 368,944
Unrecognized compensation cost related to non-vested stock option	$ 269,490		$ 269,490
Share-based arrangement, non-vested weighted average period			9 months 7 days
Sales and marketing expense
SHARE-BASED PAYMENTS
Stock-based compensation expense			$ 43,197	$ 43,196

LEASE OBLIGATIONS (Details)

LEASE OBLIGATIONS (Details) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	May 31, 2023	Jan. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Operating lease agreements
Rent expense			$ 140,304	$ 267,041	$ 401,444	$ 736,523
Right of use asset			207,745		207,745		$ 102,349
Corporate office and distribution center
Operating lease agreements
Rent expense		$ 38,105
Right of use asset		$ 467,738
Discount rate		8%
Operating lease accounts payable past rent due to landlord			980,322		980,322
Showroom Space
Operating lease agreements
Rent expense	$ 6,520
Right of use asset	$ 125,397
Discount rate	8%
Operating lease accounts payable past rent due to landlord			$ 248,734		$ 248,734
Base rent increases	$ 6,781

CONTINGENCIES (Details)

CONTINGENCIES (Details)				1 Months Ended		9 Months Ended
	Mar. 21, 2023 USD ($)	Feb. 07, 2023 USD ($)	Dec. 21, 2020 USD ($)	Mar. 31, 2021 USD ($) item	Aug. 31, 2020 USD ($) item	Sep. 30, 2023 USD ($)	Nov. 09, 2022 USD ($)
Litigation Matters
Settlement amount payable to vendor							$ 50,190
Claims settled after signing long-term lease						$ 450,968
Lawsuits filed related to prior services rendered
Litigation Matters
Damages sought			$ 100,000	$ 96,900	$ 96,900
Number of lawsuit settled | item				2	2
lawsuit against Bailey 44 related to a retail store lease
Litigation Matters
Damages sought						$ 1,500,000
Non-payment of trade payables
Litigation Matters
Damages sought	$ 43,501	$ 182,400

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Pre-funded warrants - shares	Aug. 31, 2023	Jan. 11, 2023
SUBSEQUENT EVENTS
Warrants issued		802,140
Common stock
SUBSEQUENT EVENTS
Warrants issued	225,375